Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | LTA4H | P09960 | 1/20 | 0.35 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.33 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL787028 | 0.85 | BLM (0.41) | CYP1A2LTA4HBLMACE2 | |
| SCHEMBL14586573 | 0.84 | FOLH1 (0.33) | CYP1A2BLM | |
| SCHEMBL14586575 | 0.84 | BLM (0.40) | CYP1A2LTA4HBLMACE2 | |
| SCHEMBL12405769 | 0.81 | TSHR (0.41) | FFAR4FFAR1 | |
| SCHEMBL786856 | 0.81 | TSHR (0.41) | FFAR4FFAR1 | |
| SCHEMBL786863 | 0.80 | MME (0.34) | CYP1A2LTA4H | |
| SCHEMBL19700255 | 0.80 | TSHR (0.43) | FFAR4FFAR1 | |
| SCHEMBL12405770 | 0.80 | TSHR (0.43) | FFAR4FFAR1 | |
| SCHEMBL13042886 | 0.78 | LMNA (0.41) | FFAR4FFAR1 | |
| SCHEMBL13042895 | 0.77 | FOLH1 (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150166342-A1 | Functionalized Matrices for Dispersion of Nanostructures | NANOSYS, INC. (US) | 2015-06-18 | — | — | US | disclosed |
| US-8916064-B2 | Functionalized matrices for dispersion of nanostructures | NANOSYS, INC. (US) | 2014-12-23 | — | — | US | disclosed |
| US-20140151600-A1 | Functionalized Matrices for Dispersion of Nanostructures | NANOSYS, INC. (US) | 2014-06-05 | — | — | US | disclosed |
| US-20130043433-A1 | Functionalized Matrixes for Dispersion of Nanostructures | NANOSYS, INC. (US) | 2013-02-21 | — | — | US | disclosed |
| US-20120068118-A1 | NANOCRYSTAL DOPED MATRIXES | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2012-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120068118-A1 | NANOCRYSTAL DOPED MATRIXES | STRA6, EPHA6, PIR | CYP1A2 4339/4885LTA4H 3713/4885FFAR4 4863/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.